Haruko, a cutting-edge company specializing in vertically integrated blockchain infrastructure and a comprehensive digital asset platform for institutional investors, has recently secured an impressive $6,000,000 in funding. This substantial investment will be pivotal in further enhancing Haruko's already renowned tech solution, which facilitates seamless connectivity between CeFi exchanges and DeFi protocols, providing users with a comprehensive real-time overview of their digital asset portfolio and associated risks. By amalgamating industry-leading financial practices with state-of-the-art blockchain technology, Haruko assures a unified, trusted, and user-friendly digital asset management experience. This funding injection marks an exciting new chapter for Haruko as they continue to revolutionize the digital asset landscape. Explore the possibilities with a personalized Haruko demo and discover how this investment is set to further elevate their industry-leading offerings.
Haruko Secures $6 Million in Series A Funding to Revolutionize Digital Asset Management for Institutional Investors
Recently funded · $6.0M Series aFinancial Technology
Get the full Haruko company profile
Access contacts, investors, buying signals & more
Other recently funded companies
View all
Aisot Technologies
Aisot Technologies is a Zurich-based AI company pioneering advanced, AI-driven investment solutions. Spun out of ETH Zurich in 2021, aisot leverages machine learning, large language models (LLMs), and quantitative methods to deliver precise, real-time investment insights. Its AI Insights Platform empowers asset managers, funds, family offices, and treasuries to anticipate market trends, optimize strategies, and mitigate risk. Recognized across Europe and the U.S., aisot partners with leading financial institutions to redefine quantitative investment management.
$2.5M Seed
today
Dognosis
Dognosis is a deep-tech startup in Bangalore decoding canine cognition to reveal the hidden world of scent. Our vision is a world where we have cracked the olfactory code of disease, making detecting disease as easy as breathing. Our mission is to save lives by detecting disease early and advance humanity towards truly proactive and preventative medicine. Our work revolves around increasing the bandwidth of human-canine collaboration, allowing us to catch the scent of disease at scale. Our first goal is to solve for early cancer detection by pioneering a multi-cancer breath-based test - BreathEasy - that will be ultra-affordable, highly accurate, and super accessible. We're always on the lookout for passionate and ambitious people to work with us. Feel free to say hi to woof@dognosis.tech
Other recent Series a rounds
Companies that recently closed a Series a round.
| # | Company | Round | Amount | Date |
|---|---|---|---|---|
| 1 |  Aligned Marketplace | Series a | $20.0M | today |
| 2 |  Vals AI United States | Series a | $40.0M | today |
| 3 |
.png&w=3840&q=75)
